A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gloria Lee, MD, PhD
HUYABIO International, LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Western Regional Medical Center
Goodyear, Arizona, United States
- Cbcc Global Research, Inc at Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Hematology Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida, United States
- Southeastern Regional Medical Center
Newnan, Georgia, United States
- Midewestern Regional Medical Center, Llc
Zion, Illinois, United States
- Cotton O'Neil Clinical Research Center
Topeka, Kansas, United States
- Frederick Health-Jmsci
Frederick, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Feb 2022
- Primary completion
- 19 Apr 2023
- Completion
- 19 Apr 2023
- Last update posted
- 24 Dec 2025
- Registered enrollment
- 5
- Registry id
- NCT05141357
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.